Sign In
Buy CRSP
$46.99
-0.790 (-1.65%)
At Close: Jul 20, 2026
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term
08:50am, Monday, 23'rd Dec 2024
These five geonomics and synthetic biology stocks are likely to soar in the short-term. They Are: CRSP, IMCR, GLUE, RIGL, CSTL.
This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?
12:25pm, Sunday, 22'nd Dec 2024
What's going on with CRISPR Therapeutics (CRSP 0.83%)? The company's shares have been southbound for the better part of three years.
1 big new Green Flag for CRISPR Therapeutics' Stock
09:30am, Friday, 20'th Dec 2024
CRISPR Therapeutics (CRSP -1.64%) isn't a stock that's wanting for reasons to invest. Between the solid launch of its first commercialized therapy and a promising pipeline that's continuing to deliver
3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025
10:01am, Tuesday, 17'th Dec 2024
We have picked three biotech stocks with promising gene therapies in their portfolios/pipelines that are likely to perform well in 2025.
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
05:29am, Tuesday, 17'th Dec 2024
Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are a pair of biopharma stocks that Wall Street expects to rocket higher in
3 Things You Need to Know if You Buy CRISPR Therapeutics Today
09:45am, Saturday, 14'th Dec 2024
CRISPR Therapeutics (CRSP -3.57%) is recognized as a pioneer in the field of gene therapy. This biotechnology has the potential to revolutionize medicine through precise modifications of a person's DN
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
12:00pm, Monday, 09'th Dec 2024
-Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a standard lymphodepletion protocol-
CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?
06:47am, Monday, 09'th Dec 2024
CRISPR Therapeutics (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 Biotech Stocks to Buy Hand Over Fist in December
08:45am, Saturday, 07'th Dec 2024
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% this year compared to 28% for the S&P 500.
Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?
12:36pm, Thursday, 05'th Dec 2024
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock?
3 of the Best Growth Stocks You Can Buy for Less than $100
05:27am, Thursday, 05'th Dec 2024
It's getting harder these days to find great growth stocks trading for less than $100 a share. It almost seems like a higher price is one of the criteria.
Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a Bet
06:45pm, Monday, 02'nd Dec 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 58.3% in CRISPR Therapeutics (CRSP). While the effectiveness of this highly sought-after metric is questionable
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
04:35am, Saturday, 30'th Nov 2024
Ark Invest chief Cathie Wood is known for scooping up shares of innovators early in their growth stories and holding on for the long term. The idea is to get in on these players for a bargain price, a
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
05:47am, Sunday, 24'th Nov 2024
On Nov. 21, shares of CRISPR Therapeutics (CRSP 3.44%) were down 47% from a peak they reached in March. This might be a little surprising to folks who have been following this developer of gene therap
3 Monster Stocks in the Making
06:30am, Saturday, 23'rd Nov 2024
3 Monster Stocks in the Making
